NDC 24623-042

Advanced Lightning

Octinoxate And Hydroquinone

Advanced Lightning is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Cbi Laboratories, Inc. The primary component is Octinoxate; Hydroquinone.

Product ID24623-042_bb41140c-ef5b-4c97-96a2-4a0af804f5e1
NDC24623-042
Product TypeHuman Otc Drug
Proprietary NameAdvanced Lightning
Generic NameOctinoxate And Hydroquinone
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2005-07-01
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart352
Labeler NameCBI Laboratories, Inc
Substance NameOCTINOXATE; HYDROQUINONE
Active Ingredient Strength0 g/g; g/g
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 24623-042-22

56.7 g in 1 JAR (24623-042-22)
Marketing Start Date2005-07-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 24623-042-22 [24623004222]

Advanced Lightning CREAM
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2005-07-01
Inactivation Date2019-10-29

Drug Details

Active Ingredients

IngredientStrength
OCTINOXATE.02 g/g

OpenFDA Data

SPL SET ID:f3eea4bf-440b-43cc-96a0-19f543d0adf4
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.